Milne George M JR
SEC-identified person · CIK 1179552 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Amylyx Pharmaceuticals, Inc. AMLX | Director | filed 2022–2026 |
| Aurinia Pharmaceuticals Inc. AUPH | Director | filed 2021–2023 |
| Charles River Laboratories International, INC. CRL | Director | filed 2006–2021 |
| Mettler Toledo International INC/ MTD | Director | filed 2006–2016 |
| Bthc VI Inc NA | Director | filed 2007–2011 |
| Medimmune INC /DE MEDI | Director | filed 2006–2007 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.